Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • NGS group
    Member
    • Apr 2013
    • 28

    Comparing the quality of de novo assembly from two runs' data

    We are using Miseq to sequence microbial genomes (~5Mb). In the first run (1#), library containing 12 samples were sequenced, and 6 samples were sequenced in the other run (2#). Obviously, the data of the 2# run have higher coverage depth that those of the 1# run. Therefore, I expected that the quality of de novo assembly data of the 2# run should be better than those of the 1#run. After analyzing by CLC Bio, I found that it is not true. Each sample from these two runs are shown as follow:

    Sample of 1# run Sample of 2# run
    N50 192439 261691
    Max length 461804 450288
    Average length 38501 8334
    Count of contig 145 688

    I dont understand why there are more contigs of 2# run that 1# run? Is that because of the high coverage? And how about the de novo assembly of these two runs?

    Thank you very much!
  • NGS group
    Member
    • Apr 2013
    • 28

    #2
    Is there anyone can help me????

    Comment

    • krobison
      Senior Member
      • Nov 2007
      • 734

      #3
      Some of your question is specific to CLC bio, which I don't use.

      What theoretical coverage did you actually achieve in the experiments? Are you using paired ends? What read lengths? What does the quality profile & insert size distribution look like for each? Are your samples very closely related, or perhaps not?

      If the libraries are quite different & poorer libraries are concentrated in the second run, then that might explain things.

      Comment

      • NGS group
        Member
        • Apr 2013
        • 28

        #4
        Krobison, thanks for your reply. The coverage of the 2# run is around 140x. I used paired ends 2x250. The insertion size of the 2# run looks longer than that of the 1# run from Bioanalyzer data. The samples are very closely related.


        Originally posted by krobison View Post
        Some of your question is specific to CLC bio, which I don't use.

        What theoretical coverage did you actually achieve in the experiments? Are you using paired ends? What read lengths? What does the quality profile & insert size distribution look like for each? Are your samples very closely related, or perhaps not?

        If the libraries are quite different & poorer libraries are concentrated in the second run, then that might explain things.

        Comment

        Latest Articles

        Collapse

        • mylaser
          Reply to Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by mylaser
          The world of online gaming has grown tremendously over the past few years, giving players access to exciting sports, casino games, and interactive entertainment from the comfort of their homes. Among the platforms gaining attention, Kheloyaar has become a trusted destination for users seeking a fast, secure, and engaging gaming experience.
          Whether you're a first-time visitor or an existing user, understanding the features of Kheloyar and the Kheloyaar login process can help you enjoy everything...
          Today, 12:33 AM
        • SEQadmin2
          Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
          by SEQadmin2


          Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

          The systematic characterization of the human proteome has
          ...
          Yesterday, 11:48 AM
        • SEQadmin2
          Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
          by SEQadmin2



          Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
          ...
          07-09-2026, 11:10 AM

        ad_right_rmr

        Collapse

        News

        Collapse

        Topics Statistics Last Post
        Started by SEQadmin2, Yesterday, 11:10 AM
        0 responses
        8 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-13-2026, 10:26 AM
        0 responses
        30 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-09-2026, 10:04 AM
        0 responses
        39 views
        0 reactions
        Last Post SEQadmin2  
        Started by SEQadmin2, 07-08-2026, 10:08 AM
        0 responses
        25 views
        0 reactions
        Last Post SEQadmin2  
        Working...